Get the Stockscreener App
164.56
4.07%
6.44
After Hours:
164.36
-0.20
-0.12%
Icon Plc stock is traded at $164.56, with a volume of 1.34M.
It is up +4.07% in the last 24 hours and down -14.85% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$158.12
Open:
$157.76
24h Volume:
1.34M
Relative Volume:
1.37
Market Cap:
$13.29B
Revenue:
$8.19B
Net Income/Loss:
$758.19M
P/E Ratio:
17.93
EPS:
9.18
Net Cash Flow:
$1.06B
1W Performance:
+1.47%
1M Performance:
-14.85%
6M Performance:
+29.96%
1Y Performance:
-22.65%
1-Day Range:
$155.66
$165.49
1-Week Range:
$154.12
$165.49
52-Week Range:
$125.10
$228.28
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
164.56 | 12.07B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
Icon Plc (NASDAQ:ICLR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Icon Plc $ICLR Shares Sold by Westfield Capital Management Co. LP - MarketBeat
Brandywine Global Investment Management LLC Has $51.12 Million Position in Icon Plc $ICLR - MarketBeat
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Icon Plc $ICLR is Eagle Health Investments LP's 5th Largest Position - MarketBeat
Napean Trading & Investment Co Singapore PTE Ltd Cuts Holdings in Icon Plc $ICLR - MarketBeat
SG Americas Securities LLC Buys 1,743 Shares of Icon Plc $ICLR - MarketBeat
Artisan Partners Limited Partnership Buys 2,893,946 Shares of Icon Plc $ICLR - MarketBeat
Precision Trading with Icon Plc (ICLR) Risk Zones - news.stocktradersdaily.com
Massachusetts Financial Services Co. MA Has $545.73 Million Holdings in Icon Plc $ICLR - MarketBeat
Boston Partners Cuts Holdings in Icon Plc $ICLR - MarketBeat
Wellington Management Group LLP's Strategic Acquisition of Icon PLC Shares - GuruFocus
Icon Plc $ICLR Shares Sold by Vestmark Advisory Solutions Inc. - MarketBeat
ICON plc to Present at Jefferies London Healthcare Conference - MSN
Riding the data wave: How pharma can navigate disruptions in open claims, Upcoming Webinar Hosted by Xtalks - The Malaysian Reserve
ICON Public Limited Company (ICLR) Soared on Robust Performance - Finviz
Robeco Schweiz AG Decreases Holdings in Icon Plc $ICLR - MarketBeat
Mawer Investment Management Ltd. Sells 310,086 Shares of Icon Plc $ICLR - MarketBeat
ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
Laffer Tengler Investments Inc. Invests $305,000 in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Forecasts - Yahoo Finance
Bank of Montreal Can Buys 24,850 Shares of Icon Plc $ICLR - MarketBeat
Bryn Mawr Trust Advisors LLC Invests $299,000 in Icon Plc $ICLR - MarketBeat
Atria Investments Inc Cuts Stock Position in Icon Plc $ICLR - MarketBeat
Ronald Muhlenkamp's Strategic Move: Icon PLC Takes Center Stage with 3.49% Portfolio Share - GuruFocus
Trillium Asset Management LLC Lowers Stock Holdings in Icon Plc $ICLR - MarketBeat
Bessemer Group Inc. Reduces Stock Position in Icon Plc $ICLR - MarketBeat
ICON plcOrdinary Shares (NQ: ICLR - Markets Financial Content
Equity Investment Corp Invests $82.26 Million in Icon Plc $ICLR - MarketBeat
Fullcircle Wealth LLC Makes New Investment in Icon Plc $ICLR - MarketBeat
Envestnet Asset Management Inc. Sells 211,892 Shares of Icon Plc $ICLR - MarketBeat
Cash per share of ICON Plc – FWB:IJF - TradingView
Icon Plc $ICLR Shares Acquired by Cambiar Investors LLC - MarketBeat
Firetrail Investments PTY Ltd. Grows Position in Icon Plc $ICLR - MarketBeat
Two Creeks Capital Management, LP's Icon PLC(ICLR) Holding History - GuruFocus
HBK Sorce Advisory LLC Purchases Shares of 2,829 Icon Plc $ICLR - MarketBeat
Arkadios Wealth Advisors Buys 2,354 Shares of Icon Plc $ICLR - MarketBeat
Oppenheimer Asset Management Inc. Sells 9,690 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Fisher Funds Management LTD - MarketBeat
ICON suspends COVID vaccine study after BARDA notice - MSN
Buckhead Capital Management LLC Increases Stock Position in Icon Plc $ICLR - MarketBeat
Live Oak Private Wealth LLC Purchases 3,277 Shares of Icon Plc $ICLR - MarketBeat
Icon PLC (ICLR) Stock Price, Trades & News - GuruFocus
A Look at ICON’s (ICLR) Valuation After Q3 Results, Guidance Raise, and Tech Investments - simplywall.st
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments - MSN
Clinical Real World Data Market Set to Witness Massive Growth - openPR.com
Icon (ICLR) Shares Cross Below 200 DMA - Nasdaq
Pettee Investors Inc. Trims Stock Position in Icon Plc $ICLR - MarketBeat
First Pacific Advisors LP Increases Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Peregrine Capital Management LLC - MarketBeat
5,284 Shares in Icon Plc $ICLR Purchased by Brighton Jones LLC - MarketBeat
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):